Skip to main content

Neuraptive Therapeutics

Lafayette, United States

Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries.

$7.5M raised
Oct 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Neuraptive Therapeutics

How much funding has Neuraptive Therapeutics raised?
Neuraptive Therapeutics has raised $7.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2022.
Who are Neuraptive Therapeutics's investors?
Neuraptive Therapeutics's investors include Ben Franklin Technology Partners, New Rhein, Central Texas Angel Network.
Where is Neuraptive Therapeutics headquartered?
Neuraptive Therapeutics is headquartered in Lafayette, United States.
What does Neuraptive Therapeutics do?
Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries.
What stage is Neuraptive Therapeutics at?
Neuraptive Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Neuraptive Therapeutics — Funding & Investors." VCBacked, October 25, 2022, https://www.vcbacked.co/company/neuraptive-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2022). Neuraptive Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/neuraptive-therapeutics
Wikipedia (cite web)
{{cite web |title=Neuraptive Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuraptive-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .